Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

IVF attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 8
  • 0 comments

IVF attributes changed: Attr: Fin_status N -> E;

Comment Full text

FSHP attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 11
  • 0 comments

FSHP attributes changed: Attr: Fin_status N -> E;

Comment Full text

FSHPR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 12
  • 0 comments

FSHPR attributes changed: Attr: Fin_status N -> E;

Comment Full text

FSHPU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 14
  • 0 comments

FSHPU attributes changed: Attr: Fin_status N -> E;

Comment Full text

EXFY attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 14
  • 0 comments

EXFY attributes changed: Attr: Fin_status N -> D;

Comment Full text

ESHA attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 13
  • 0 comments

ESHA attributes changed: Attr: Fin_status N -> E;

Comment Full text

ESHAR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 15
  • 0 comments

ESHAR attributes changed: Attr: Fin_status N -> E;

Comment Full text

CELU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 13
  • 0 comments

CELU attributes changed: Attr: Fin_status N -> E;

Comment Full text

CELULARITY INC (CELUW)

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 11
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

CELUW attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 17
  • 0 comments

CELUW attributes changed: Attr: Fin_status N -> E;

Comment Full text
  • Previous
  • 214
  • 215
  • 216
  • 217
  • 218
  • Next

Search

News categories

  • Technical Exchange News(14191)
  • Event(6229)
  • SEC News(362514)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222908)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin